Triglyceride-glycated hemoglobin index as a superior predictor of type 2 diabetes risk in a large-scale retrospective
Changchun Cao1,2, Yibing Zan2, Yong Han3
1Department of Rehabilitation, Longgang E.N.T Hospital & Shenzhen Key Laboratory of E.N.T, Institute of Ear Nose Throat (E.N.T), Shenzhen, 518000, Guangdong Province, China.
Abstract:
Early detection of individuals at elevated risk for type 2 diabetes (T2D) is critical for effective prevention strategies. We developed a novel metabolic marker, the triglyceride-glycated hemoglobin index (TyH-i), which integrates lipid and glycemic parameters to improve T2D risk prediction. This study sought to evaluate the relationship between TyH-i and T2D risk and to examine its predictive performance with the triglyceride-glucose index (TyG-i). A large-scale retrospective cohort study was conducted using data from 15,464 Japanese adults without T2D at baseline. The TyH-i was calculated as Ln[glycated hemoglobin index (%)×triglycerides (mg/dL)/2], and its association with incident T2D was assessed using Cox proportional hazards models and smooth curve fitting and cubic spline functions. The predictive performance of the TyH-i was compared with the TyG-i using receiver operating characteristic curves. Over a median follow-up of 5.39 years, 373 participants developed T2D. After accounting for confounders, the TyH-i was significantly associated with T2D risk (HR: 1.55, 95% CI: 1.22-1.97, P = 0.00031). Additionally, a J-shaped relationship between the TyH-i and incident T2D was identified. A significant positive correlation was identified between TyH-i and T2D only when TyH-i levels were above 4.92 (HR: 1.73, 95%CI: 1.35-2.23, P < 0.0001). Furthermore, TyH-i and TyG-i possess comparable discriminatory ability in predicting incident T2D (AUC: 0.751 vs. 0.750, P = 0.8873). Moreover, TyH-i yielded lower Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC) values than TyG-i (AIC: 3211.60 vs. 3211.91; BIC: 3226.89 vs. 3227.20), indicating a more parsimonious model with better overall model fit. The TyH-i is a novel and effective predictor of T2D risk, exhibiting a non-linear relationship with T2D. Furthermore, TyH-i and TyG-i exhibit comparable discriminatory abilities in predicting incident T2D. These results highlight the potential of TyH-i as a valuable instrument for T2D risk stratification, particularly in individuals with elevated TyH-i levels.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...


